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Abstract
The objective of the study was to investigate the in-vivo anti-tumour activity of Spica prunellae extract, and to
preliminarily explore the possible mechanism of in-vivo anti-tumour effect of Spica prunellae extract. Tumour inhibition rate
and tumour apoptosis-related protein status were determined using the mice model of transplanted T lymphoma
cell EL-4 tumour, and by immunohistochemical method. The results revealed that Spica prunellae extract showed certain
tumour inhibitory effect, and compared with the model group. Tumour weight in Spica prunellae high-dose group was
highly significantly different (P<0.01). Tumour weight in Spica prunellae medium-dose group was also
significantly different (P<0.05) compared with the model group. Spica prunellae high-dose group enabled the high
expression of Bcl-2 protein (47.54%) and low expression of Bax protein (13.14%). The study concluded that Spica prunellae
extract has certain in vivo anti-tumour effect, which may be achieved through regulation of apoptosis related
proteins.
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Introduction
Spica prunellae is the dried fruit-spike of Prunella vulgaris L., which is in the genus Prunella, family Lamiaceae. It can clear
liver fire, improve eyesight, and disperse swelling, and is mainly used in the treatment of swollen eyes, eyeball pain at night,
headaches, dizziness, and swollen breasts (China Medical Science Pree, 2010). It gets its name as it "withers soon after the
summer solstice" (Chinese Pharmacopoeia Commission, 2010). Its dried mature fruit-spike has been medicinally used in
China for many centuries. According to the records of "Shen Nong's Herbal Classic," "Spica prunellae is bitter and pungent
in taste, and is mainly used in the treatment of scrofula, head sores, lump pain, goiter, knot..." (Han Wu-xiang, 2006) As early
as in 1988, Lee et al. (Lee KH, et al., 1988) found through in vitro study that the rich ursolic acid contained in
Prunella vulgaris had a significant cytotoxic activity on A549 human lung adenocarcinoma cells and L1210 leukaemia cells.
(Wang Ping, et al., 2010). In vitro apoptosis experiments have suggested that it can induce apoptosis of SGC-7901 gastric
cancer cells and K562 human erythroleukemia cells (Wang Kun, et al., 2000; Zhang Ke-jie, et al., 2005). Horikawa K, et
al. (Horikawa K, et al., 1994) found that the Prunella plants had an obvious antagonistic effect against carcinogenic and
mutagenic actions of benzo[a]pyrene. Modern clinical experience has shown that Spica prunellae, whether used alone or
combined with other medicines, has a good therapeutic effect for the treatment of various malignant tumours such as lung
cancer (Lan Hong-qin, et al., 2007; Li Yan, 2008), breast cancer (Gu Yan-fang, et al., 2002), brain glioblastoma (Tu Yun, et
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al., 2007), and lymphoma (Zhou Jian-hua & Xu Ai-hua, 2005). In this paper, mouse model of transplanted T lymphoma
cell EL-4 tumour was established to observe the in-vivo anti-tumour activity of Spica prunellae extract, and
immunohistochemical techniques were applied to preliminarily explore the possible mechanism of in-vivo anti-tumour effect
of Spica prunellae extract.
Experimental Materials
Drugs and reagents
Spica prunellae was purchased from Xinxiang Pharmaceutical Co., Ltd. DMEM medium (Beijing Borunlaite Science
& Technology Co., Ltd.), which was identified by Professor Wang Kun, and placed at experiment centre (JM-2314-KL).
Other reagents included foetal horse serum (Beijing Biodee Biotechnology Co., Ltd.), trypsin (Jiangsu Yake Chemical Co.,
Ltd.), MTT (Sigma-Aldrich), cyclophosphamide (Jiangsu Hengrui Medicine Co., Ltd.), mouse anti-mouse Bcl-2 monoclonal
antibody concentrate (Beijing ZhongShan Golden Bridge Biotechnology Co., Ltd.), mouse anti-mouse Bax monoclonal
antibody concentrate (Beijing ZhongShan Golden Bridge Biotechnology Co., Ltd.), Streptavidin-Peroxidase Histostain
TM-Plus Kit (Beijing ZhongShan Golden Bridge Biotechnology Co., Ltd.), and DAB chromogenic kit (Beijing ZhongShan
Golden Bridge Biotechnology Co., Ltd.). Other reagents were of domestic analytical grade.
Main instruments
The main instruments used for the study included the following: NUAIRE US AUTOFLOW CO2 incubator
(NUAIRE, Germany); SW-CJ-IF clean bench (Suzhou Purification Equipment Factory); AE31 inverted phase contrast
microscope (Motic Group); Mod550 fully automated microplate reader (BioRad, USA); stainless steel positive pressure filter
(Haining Yatai Pharmaceutical Machinery Co., Ltd.); sterile 96-well culture plate (Costar); RE-52AA rotary evaporator
(Shanghai Ya Rong Biochemical Instrument Factory); HH-8 digital thermostat water bath (Changzhou Guohua Electric
Appliance Co., Ltd.); electronic balance (Beijing Sartorius Instrument System Co., Ltd.); DZF-6020 vacuum oven (Shanghai
Yiheng Instruments Co., Ltd.); hemacytometer (Shanghai Qiujing Biochemical Instrument Factory).
Experimental animals
C57BL/6 inbred mice, weighing 18~22 g, were purchased from the Laboratory Animal Center of Xinxiang Medical
University. All experimental procedures were approved by the Animal Research Ethics Committee of Yunnan Medical
College University
Cell lines
Mouse T lymphoma leukaemia cell lines EL-4 were purchased from the Cell Center, Institute of Basic Medical
College, Peking Union Medical College.
Preparation of Spica prunellae extract
Dried Spica prunellae was crushed and an appropriate amount was weighed. It was then added with a
25-fold volume of 60% ethanol and ultrasonically extracted three times with 30 min each. The extracted solutions
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were combined, cryoconcentrated, and then purified by polyamide resin. After the effluent was cryoconcentrated
and freeze-dried, Spica prunellae extract powder was obtained.
Cell cultivation
EL-4 cells were grown in suspension in DMEM high glucose medium containing 10% foetal horse serum, and
cultured routinely under the conditions of a temperature of 37℃, CO2 concentration of 5%, and saturated humidity. Cells
were passaged once every three days, and cells after thawing were regarded as the first generation cells. In this experiment,
the third generation cells after thawing were used.
Model establishment (Li Yi-kui, et al., 2006)
Cells in the logarithmic growth phase were collected, prepared as a 1×107 cells/mL single-cell suspension with sterile
saline. They were subcutaneously inoculated in the right axilla of C57BL/6 mice, with an inoculum concentration of 0.2 ml
cell suspension/mouse. After EL-4 cells were stably passaged in mice, EL-4 tumour-bearing mice on the 14th day after
passaging were sacrificed by cervical dislocation. Tumour tissues were harvested from the axilla in a clean bench. Under
sterile conditions, fibrous capsules and necrotic tissues were removed, and well-grown tumour tissues were picked out, cut
into pieces in a sterile dish, gently ground in a tissue grinder by adding appropriate amount of normal saline, and then filtered
with a 200 mesh nylon filter to prepare the tumour cell suspension. After staining with 0.4% trypan blue, cells were counted
on the haemocytometer. Cell viability was greater than 95%, and cell concentration was adjusted to 4×105 cells/mL with
sterile saline. 0.2 mL of the above tumour cell suspension was taken and inoculated subcutaneously into the right axilla of
C57BL/6 mice.
Grouping and treatment
24 hours after inoculation, 50 mice were randomly divided into model groups – cyclophosphamide group and Spica
prunellae extract high-, medium-, and low-dose groups, – a total of 5 groups with 10 mice each. All mice were given enough
water and food, and mice in each group were weighed and recorded. Method of administration and dose were determined
referring to Yao Zhi-hua (2006) as well as the method provided in the “Experimental Methodology of Pharmacology” (Xu
Shu-yun, et al., 1991). Spica prunellae high-, medium-, and low-doses were 600 mg crude drug/Kg, 400 mg crude
drug/Kg, and 200 mg crude drug/Kg respectively. The mental state, activities and feeding status of mice were observed on
a daily basis.
Determination of tumour inhibition rate
On the 11th day after administration, mice were weighed and sacrificed. Tumours were harvested and weighed. The
tumour inhibition rate was calculated according to the following formula:
Tumour inhibition rate = (average tumour weight of the control group - average tumour weight of the experimental
group) / average tumour weight of the control group × 100%
Determination of apoptosis-related gene protein expression by immunohistochemical method
(1) Paraffin sections were dewaxed, and placed in water.
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(2) The sections were rinsed with distilled water, soaked in PBS for 5 min, and then antigen heat-retrieved for 1 h.
(3) Sections were added dropwise with 3% hydrogen peroxide, incubated at 37℃ for 10 min to eliminate endogenous
peroxidase activity, and then washed in PBS three times with 5 min each.
(4) Sections were added dropwise with 5% normal goat serum to block non-specific binding sites, so as to eliminate
non-specific staining, incubated at 37℃ for 30 min, and decanted instead of washing.
(5) Sections were added dropwise with primary antibody working solution (mouse anti-mouse BCI-2 monoclonal
antibody, mouse anti-mouse Bax monoclonal antibody), and incubated at 37℃ in wet box overnight.
(6) Sections were washed in PBS three times, with 5 min each.
(7) Sections were added dropwise with biotin-labelled secondary antibody working solution, and incubated at 37℃
for 30 min.
(8) Sections were washed in PBS three times, with 5 min each.
(9) Sections were added dropwise with horseradish peroxidase-labelled streptavidin, and incubated at 37℃
for 30 min.
(10) Sections were washed in PBS three times, with 5 min each.
(11) Sections were developed with DAB.
(12) Sections were thoroughly rinsed with tap water, counterstained, dehydrated and cleared in xylene, and mounted
in neutral balsam.
Judgement of immunohistochemical staining results for expression of bcl-2 and bax proteins in EL-4 transplanted
tumour tissues in mice
Appearance of yellowish-brown or tan granules in the cytoplasm was regarded as positive. 10 high power fields were
randomly selected for counting; 100 cells were counted per high power field, which totalled 1000 cells, and the bcl-2 or
bax positive cell ratio (%) was calculated. EL-4 transplanted tumour tissues of mice where drug was not administered were
served as the blank control. Counting was performed by at least two individuals, and averaged.
Statistical methods
Experimental data were analysed using SPSS 13.0 software. Comparison between two groups was
performed using t-test, and pairwise comparisons among groups were performed using one-way analysis of
variance.
Experimental Results
Effect of Spica prunellae extract on body weight of mice
The changes in body weight of mice before and after the experiment are as shown in Table 3-1. Except for
the cyclophosphamide group where weight gain was not obvious, body weights were significantly increased in all
of the experimental groups, although the increases were less when compared with the model group. Basically, the
amount of increase was negatively correlated with the dose.
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Effect of Spica prunellae extract on tumour weight and tumour inhibition rate
The results for the effect of Spica prunellae extract on tumour weight and tumour inhibition rate are
shown in Table 3-2. Tumour weight in Spica prunellae high-dose group was highly significantly different
(P<0.01) compared with the model group. Tumour weight in Spica prunellae medium-dose group was also
significantly different (P<0.05) compared with the model group, and the tumour inhibition rates of the two groups
were both greater than 30%, suggesting that the Spica prunellae extract can significantly inhibit solid tumour
development in EL-4 tumour-bearing mice. Tumour weight in Spica prunellae low-dose group was also reduced
compared with the model group, but revealed no significant difference.
Table 1: Effect of Spica prunellae extract on changes in body weight of EL-4 tumour-bearing mice before and
after experiment (
—
X ±S, n=10)
Group Dose (mg crude
drug/Kg)
Number of
animals
Average body
weight (g) of mice
before experiment
Average body
weight (g) of mice
after experiment
Model group 10 21.98±2.51 29.46±4.13
Cyclophosphamide
group
0.02g 10 21.42±2.78 24.24±3.77
Spica prunellae
high-dose group
600 10 21.74±2.29 27.69±4.45
Spica prunellae
medium-dose group
400 10 21.36±2.78 28.88±4.75
Spica prunellae
low-dose group
200 10 21.53±2.19 29.23±5.22
Table 2: Effect of Spica prunellae extract on tumour weight and tumour inhibition rate of EL-4 tumour-bearing
mice
Group Dose (mg crude
drug/Kg)
Number of
animals
Tumour
weight (g)
Tumour inhibition
rate (%)
Model group 10 2.32±0.57
Cyclophosphamide
group
0.02g 10 0.68±0.34** 70.69
Spica prunellae
high-dose group
600 10 1.15±0.39** 50.43
Spica prunellae
medium-dose group
400 10 1.38±0.34* 40.52
Spica prunellae
low-dose group
200 10 1.75±0.44 24.57
Comparison with the model group, * P<0.05; ** P<0.01
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Effect of Spica prunellae extract on expression of apoptosis-related genes Bcl-2 and Bax proteins
The effect of Spica prunellae extract on expression of apoptosis-related genes Bcl-2 and Bax proteins is shown in
Table 3-3. Compared with the model group, Bcl-2 protein expression decreased while Bax protein expression increased in the
transplanted tumour tissues of the Spica prunellae high-dose group, which were both statistically significant (P<0.01)
compared with the model group.
Table 3: Effect of Spica prunellae extract on expression of apoptosis-related genes Bcl-2 and Bax proteins
Group Bcl-2 protein expression ratio (%) Bax protein expression ratio (%)
Model group 47.54±2.34 13.14±1.17
Spica prunellae high-dose group 5.68±0.25** 34.56±0.74**
Comparison with the model group, ** P<0.01
Discussion
Over the years, although researches on the pathogenesis and control of lymphoid and haematopoietic tumours have
made great progress, there still remain many difficulties to be resolved. The search for efficient and low-toxic antineoplastic
drugs from different sources is still a top priority. In recent years, due to the advantages of low toxicity, little side effects, and
easy acceptance by patients of the traditional Chinese medicines, the anti-tumour active ingredients extracted from them are
gaining increasing attention (Liu Xiao, et al., 2011). This study also proved that the prepared Spica prunellae extract did
have anti-tumour effects. The induction of tumour cell apoptosis is one of the recognised anti-tumour mechanisms. The
apoptosis is the self-destructive process of cells regulated by genes, which involves a series of gene expression cascades. The
genes identified to be associated with apoptosis so far can be categorised into three: pro-apoptotic genes, anti-apoptotic genes,
and the ones that assist in the process of apoptosis. BCl-2 and its family can prevent the occurrence of apoptosis (Yang, et al.,
1997), and are associated with tumour cell proliferation and carcinogenesis, while Bcl-2-related x protein (bax) can promote
the apoptosis (Cheng EH, et al., 1997). In this study, Bcl-2 protein is highly expressed (47.54%) in the EL-4 tumour
tissues of mice in the drug groups, while Bax protein is lowly expressed (13.14%), suggesting that this may be one of the
causes for mouse EL-4 tumour cell apoptosis.
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